AUM $9.2MER 0.65%NAV $61.13Holdings 59Inception Nov 2023
Price Chart
Key Statistics
Previous Close
$62.88Day Range
N/A52-Week Range
$50.40$64.66
Avg Volume
338Dividend Yield
0.89%Expense Ratio
0.65%AUM
$9.2MShares Outstanding
199.8KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 73.81% |
| Other | 6.86% |
| United Kingdom | 6.64% |
| Switzerland | 5.44% |
| Japan | 2.66% |
| Israel | 1.84% |
| Germany | 1.51% |
| Denmark | 0.63% |
| Ireland | 0.63% |
Fund Information
- Issuer
- J.P. Morgan
- Category
- Healthcare
- Inception Date
- Nov 1, 2023
- Exchange
- NASDAQ
- Description
- The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Similar ETFs
The JPMorgan Healthcare Leaders ETF (JDOC) is an exchange-traded fund issued by J.P. Morgan that launched on Nov 1, 2023. It currently manages $9.2M in assets under management. The fund charges an expense ratio of 0.65%. The fund holds 59 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 46.7% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ABBV | ABBVIE INC COMMON STOCK | 8.00% | 2,858 | $729K |
| 2 | LLY | ELI LILLY AND COMPANY | 7.56% | 613 | $688K |
| 3 | MRK | MERCK & CO INC COMMON | 5.34% | 3,359 | $486K |
| 4 | JNJ | JOHNSON & COMMON | 4.99% | 1,706 | $454K |
| 5 | TMO | THERMO FISHER SCIENTIFIC | 4.12% | 622 | $375K |
| 6 | UNH | UNITEDHEALTH GROUP INC | 3.71% | 871 | $338K |
| 7 | AZN.L | ASTRAZENECA PLC COMMON | 3.60% | 2,065 | $328K |
| 8 | BMY | BRISTOL-MYERS SQUIBB CO | 3.47% | 4,962 | $316K |
| 9 | ABT | ABBOTT LABORATORIES | 3.03% | 2,669 | $276K |
| 10 | — | NOVO NORDISK A/S COMMON | 2.92% | 6,019 | $266K |
| 11 | ROP.SW | ROCHE HOLDING AG COMMON | 2.73% | 586 | $249K |
| 12 | DHR | DANAHER CORP COMMON | 2.47% | 1,120 | $225K |
| 13 | GSK.L | GSK PLC COMMON STOCK GBP | 2.45% | 9,313 | $223K |
| 14 | CVS | CVS HEALTH CORP COMMON | 2.38% | 2,274 | $217K |
| 15 | — | ARGENX SE COMMON STOCK | 2.37% | 218 | $215K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | -3.44% | |
| 1M | -2.21% | |
| 3M | +6.18% | |
| 6M | +8.43% | |
| YTD | +4.89% | |
| 1Y | +17.29% | |
| 3Y | +24.57% | |
| 5Y | +24.57% |
Moving Averages
20-Day MA
$62.88
Below 20-Day MA50-Day MA
$61.79
Below 50-Day MA200-Day MA
$58.40
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$64.66
Current Price
$61.43
52-Week Low
$50.40
$50.40$64.66
Current Yield
0.89%
Annual Dividend
$3.4084
Frequency
1x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.5121 | Dec 18, 2025 |
| Dec 24, 2024 | $0.3276 | Dec 27, 2024 |
| Dec 16, 2024 | $2.4890 | Dec 18, 2024 |
| Dec 19, 2023 | $0.0796 | Dec 22, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | JDOC | Healthcare(254 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.65% | 0.62% | 0.85% |
| AUM | $9.2M | $1.73B | $1.80B |
| Dividend Yield | 0.89% | 3.97% | 1.97% |
| Avg Volume | 338 | 364.4K | 1.1M |
| Holdings | 59 | 160 | 63 |
| Performance | |||
| 1-Month Return | -1.80% | -2.86% | -0.76% |
| 6-Month Return | +8.80% | +7.23% | +15.71% |
| YTD Return | +4.95% | +10.59% | +18.57% |
| 1-Year Return | +6.13% | +8.50% | +16.28% |
Compare with Another ETF
Search for an ETF to compare with JDOC:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.